LAMIN A/C GENE (LMNA) MUTATIONS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND THEIR PHENOTYPIC MANIFESTATION

This article presents the current view on the structure and functions of nuclear lamin proteins, pathological phenotypes of persons with LMNA mutations and clinical problems of lamin-related dilated cardiomyopathy diagnostics and management. Dilated cardiomyopathy (DCM) caused by mutations in the LMNA gene is often associated with conduction disorders, cardiac arrhythmias and extracardiac features with discrete muscle disruption. This disease is characterized by a poor prognosis and high risk of sudden cardiac death due to conduction disturbances (life-threatening blockade) or ventricular tachyarrhythmias (fatal ventricular tachycardias\fibrillation). We describe here 2 cases of lamin-type DCM associated with definite LMNA mutations. Educational focus for reader-cardiologist is а recognition of potential carriers followed by molecular genetic testing for diagnostics of LMNA mutation and tissues regarding optimal management of patients, especially timing for prophylactic cardioverter-defibrillator.

белки ядерной ламины, мутации гена ламина А/С (LMNA), дилатационная кардиомиопатия (ДКМП), жизнеугрожающие аритмии, кардиовертер-дефибриллятор (КВД), nuclear lamin proteins, LMNA gene mutations, dilated cardiomyopathy (DCM), life-threatening arrhythmias, cardioverter-defibrillator

1. Burke B, Stewart CL. Life at the edge: the nuclear envelope and human disease. Nat Rev Mol Cell Biol 2002; 3:575-585

2. Cohen M, Lee KK, Wilson KL, Gruenbaum Y. Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina. Trends Biochem Sci 2001; 26:41-47

3. Lammerding J, Schulze PC, Takahashi T et al. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 2004;113(3): 370-8

4. Hutchison CJ. Lamins: building blocks or regulators of gene expression? Nat Rev Mol Cell Biol 2002; 3(11): 848-58

5. Lin F, Worman HJ. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem 1993; 268:16321-16326

6. Dechat T. Nuclear lamins: Major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 2008; 22: 832-853.

7. Mattout A, Dechat T, Adam S A, Goldman and Gruenbaum Y. Nuclear lamins, diseases and aging//Current Opinion in Cell Biology 2006,18:335-341

8. Meshorer E, Gruenbaum Y. Gone with the Wnt/Notch: stem cells in laminopathies, progeria, and aging. J Cell Biol 2008; 181(1): 9-13

9. Moir R., Yoon M., Khuon S., Goldman R. Nuclear lamins A and B1: Different pathways of assembly during nuclear envelope formation in living cells. J Cell Biol 2000;151:1155-1168

10. Shimi T, Pfleghaar K, Kojima S, et al. The A- and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription //Genes Dev 2008; 22(24): 3409-3421

11. Guelen, L., Pagie, L., Brasset, E., et al. Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 2008; 453:948-951

12. Rajendran V., Purohit R., Sethumadhavan R. In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein. Amino Acids 2012; 43 (2): 603-615

13. Bonne G., Di Barletta M.R., Varnous S. et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 1999; 21:285-288

14. Fatkin D., MacRae C., Sasaki T. et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999; 341:1715-1724

15. Worman H., Ostlund C., Wang Y. Diseases of the nuclear envelope. Cold Spring Harb Perspect. Biol 2010; 2:760-776

16. Houben F. De Vos W. H. Krapels I. P. et al. Cytoplasmic localization of PML particles in laminopathies. Histochem Cell Biol 2013; 139:119-134

17. Hutchison CJ, Alvarez-Reyes M, Vaughan OA. Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes? J Cell Sci 2001; 114(1): 9-19

18. Wilson KL, Zastrow MS, Lee KK. Lamins and disease: insights into nuclear infrastructure. Cell 2001; 104(5): 647-650

19. Schirmer EC, Foisner R. Proteins that associate with lamins: many faces, many functions. Exp Cell Res 2007; 313(10): 2167-2179

20. De Vos WH, Houben F, Kamps MV et al. Repetitive disruptions of the nuclear envelope invoke temporary loss of cellular compartmentalization in laminopathies. Hum Mol Genet 2011; 20:4175-4186

21. Dhe-Paganon S1, Werner ED, Chi YI, Shoelson SE. J Structure of the globular tail of nuclear lamin. Biol Chem 2002; 277(20): 17381-17384.

22. Verdaguer N, Corbalan-Garcia S, Ochoa WF Fita et al. Ca(2+) bridges the C2 membrane-binding domain of protein kinase Calpha directly to phosphatidylserine. J EMBO 1999; 18(22): 6329-6338

23. Hershberger RE, Morales A, Siegfried JD. Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals. Genet Med 2010; 12:655-667

24. Van Tintelen J. Peter , Petronella G. Pieper, Karin Y. Van Spaendonck-Zwarts et al. Pregnancy, cardiomyopathies, and genetics. Cardiovascular Research 2014; 101:571-578

25. Jacoby D, McKenna WJ. Genetics of inherited cardiomyopathy. Eur Heart J 2012; 33:296-304

26. Fatkin D, Otway R, Richmond Z. Genetics of dilated cardiomyopathy. Heart Fail Clin 2010; 6:129-140

27. R.Weichenhan, T.M.Strom, A.Pfeufer et al. Cardiomyopathies. Targeted Next-Generation Sequencing for the Molecular Genetic Diagnostics of Cardiomiopathies. J Circ Cardiovasc Genet 2011; 4:110-122

28. Van Berlo JH, Meune C, Anselme F et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations port end a high risk of sudden death? J Mol Med 2005; 83:79-83

29. Pasotti M, Klersy C, Pilotto A, et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol 2008; 52:1250-1260

30. Ph.Charron, E. Arbustini, G. Bonne. What Should the Cardiologist know about Lamin Disease? Arrhythmia & Electrophysiology 2012; 1:22-28

31. Parks SB, Kushner JD, Nauman D et al. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. A. Heart J 2008; 56:161169

32. Meune C, Van Berlo JH, Anselme F et al. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 2006; 354:209-210

33. Fernandez X, Dumont CA, Monserrat L et al. Sudden death in a patient with lamin A/C gene mutation and near normal left ventricular systolic function. Int J Cardiol 2008; 126: 136137

34. Ehlermann P, Lehrke S, Papavassiliu T, et al. Sudden cardiac death in a patient with lamin A/C mutation in the absence of dilated cardiomyopathy or conduction disease. Clin Res Cardiol 2011; 100:547-551

35. Van Rijsingen IA, Arbustini E, Elliott PM, et al. Risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers a European cohort study. J Am Coll Cardiol 2012; 59: 493-500

36. Charron P, Arad M, Arbustini E, et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2010; 1:2715-2726

37. Frey N, Katus HA. Dilated cardiomyopathy as a genetic disease: molecular and clinical aspects. Internist 2008: 49: 43-50

38. Hershberger RE, Morales A, Siegfried JD. Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals. Genet. Med 2010; 12:655-667

39. Jacoby D, McKenna WJ. Genetics of inherited cardiomyopathy. Eur. Heart J 2012; 33:296-304

40. Fatkin D, Otway R, Richmond Z. Genetics of dilated cardiomyopathy. Heart Fail. Clin 2010; 6:129-140

41. Hugh Watkins, Houman Ashrafian, D.Phil., Charles Fedwood. Inherited Cardiomyopathies. New Engl. J Medicine 2011; 364(17): 1643-1656

42. Hershberger RE, Siegfried JD. Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. J Am. Coll. Cardiol 2011; 57:1641-1649

43. Вайханская Т.Г., Сивицкая Л.Н, Даниленко Н.Г. и соавт. Что должен знать сегодня кардиолог о дилатационной кардиомиопатии, связанной с мутацией гена ламина (LMNA)? Кардиология в Беларуси 2013; 4 (29): 64-81.